Can we lower the chances of your acute myeloid leukemia (AML) growing by adding a drug to the usual combination of drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for your AML. The usual approach is defined as care most people get for AML.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Joshua Zeidner
Medicine-Hematology
Clinical or Medical
Interventional
Cancer (Leukemia)
21-2335